Archive for Author: drsanjayagrawal

Industry approaches Centre to urgently notify methylcobalamin for neurological disorders

Shardul Nautiyal, Mumbai Friday, September 18, 2020, 08:00 Hrs The pharmaceutical industry has recently led a delegation to Union minister of chemicals and fertilizers D V Sadananda Gowda to urgently notify methylcobalamin for neurological disorders as regulatory action cannot be taken against those who are manufacturing methylcobalamin based formulations...

Read More

Peer reviewed studies show COVID-19 has long term side effects predominantly on heart, lungs and brain: Experts

Shardul Nautiyal, Mumbai Wednesday, September 16, 2020, 08:00 Hrs Though the people above 60 years old are vulnerable to COVID-19 particularly those with co-morbidities like diabetes and cardiovascular diseases, experts have corroborated peer reviewed studies substantiating that besides lung damage, COVID-19 can also damage other organs like the...

Read More

DCs, clinical experts echo similar views in support of HCQ as COVID 19 drug with clarification of no cardiotoxicity in RA patients

Shardul Nautiyal, Mumbai Wednesday, September 2, 2020, 08:00 Hrs With hydroxychloroquine (HCQ) being preferred as the first line of treatment for COVID-19 patients and state drug controllers ensuring its adequate availability in the wake of rising COVID-19 cases, drug authorities and clinical experts have clarified that HCQ has...

Read More

Antioxidants and Epilepsy

Dr Sanjay Agrawal Leading Pharmaceutical Consultant and Editor-in Chief of IJMToday Introduction Oxidative stress (OS) is the condition that occurs when the steady-state balance of prooxidants to antioxidants is shifted in the direction of the former, creating the potential for organic damage. Prooxidants are by definition free radicals, atoms,...

Read More

Experts advocate need to assess risk profile of vaccines for COVID-19 amidst WHO disapproving Russian vaccine due to lack of clinical data

Shardul Nautiyal, Mumbai Monday, August 17, 2020, 08:00 Hrs Experts have cautioned the government about the need to assess risk profile of vaccines for COVID-19 amidst reports of World Health Organization (WHO) recently disapproving Russian vaccine ‘Sputnik V’ for COVID-19 due to lack of clinical data or evidence....

Read More

FSSAI defined RDA values of methylcobalamin, vitamin C for drug and nutraceuticals for COVID-19 therapy baffles industry experts

Shardul Nautiyal, Mumbai Monday, August 10, 2020, 08:00 Hrs The Food Safety and Standards Authority of India (FSSAI) defined Recommended Dietary Allowance (RDA) value of methylcobalamin and vitamin C to boost immunity for COVID-19 has baffled industry experts as methylcobalamin and vitamin C are important nutrients for overall...

Read More